These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19817884)

  • 1. Adherence to acute migraine medication: what does it mean, why does it matter?
    Katić BJ; Krause SJ; Tepper SJ; Hu HX; Bigal ME
    Headache; 2010 Jan; 50(1):117-29. PubMed ID: 19817884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do patients want from acute migraine treatment?
    Gallagher R
    Cephalalgia; 2004; 24 Suppl 2():8-15. PubMed ID: 15595989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective).
    Rozen TD
    Headache; 2006 May; 46(5):750-3. PubMed ID: 16643577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine.
    Foley KA; Cady R; Martin V; Adelman J; Diamond M; Bell CF; Dayno JM; Hu XH
    Headache; 2005 May; 45(5):538-45. PubMed ID: 15953272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey.
    Donnet A; Lantéri-Minet M; Aucoin F; Allaf B
    Headache; 2009 Jul; 49(7):1014-21. PubMed ID: 19486362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute migraine treatment: patterns of use and satisfaction in a clinical population.
    Malik SN; Hopkins M; Young WB; Silberstein SD
    Headache; 2006 May; 46(5):773-80. PubMed ID: 16643580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying the benefits of the AwM study in the clinic.
    Dodick DW
    Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute treatment of episodic and chronic migraine in the USA.
    Bigal ME; Borucho S; Serrano D; Lipton RB
    Cephalalgia; 2009 Aug; 29(8):891-7. PubMed ID: 19222509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims.
    McHorney CA; Victor Spain C; Alexander CM; Simmons J
    Clin Ther; 2009 Nov; 31(11):2584-607. PubMed ID: 20110004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Managing the attacks, preventing headache. Migraine therapy in 2002].
    Göbel H; Heinze A; Heinze-Kuhn K
    MMW Fortschr Med; 2002 May; Suppl 2():43-50. PubMed ID: 12070849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the "difficult" headache patient.
    Baskin SM
    Neurol Sci; 2007 May; 28 Suppl 2():S78-83. PubMed ID: 17508185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beliefs about medicines and adherence among Swedish migraineurs.
    Hedenrud T; Jonsson P; Linde M
    Ann Pharmacother; 2008 Jan; 42(1):39-45. PubMed ID: 18073328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of acute migraine medications: influence of methods of assessment and relationship with headache attributes.
    Feleppa M; Apice G; D'Alessio A; Fucci S; Bigal ME
    Cephalalgia; 2008 Oct; 28(10):1012-6. PubMed ID: 18727650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
    Bigal ME; Serrano D; Reed M; Lipton RB
    Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to antipsychotic medications.
    Perkins DO
    J Clin Psychiatry; 1999; 60 Suppl 21():25-30. PubMed ID: 10548139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic issues associated with switching between triptans in clinical practice.
    Dowson AJ; Fuat A; Gruffydd-Jones K
    Curr Med Res Opin; 2005 Mar; 21(3):375-9. PubMed ID: 15811206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.